Evidence map›Paper›PMID 36222957›Full record

ReviewNeurochemical research2022

Molecular Mechanism of the Protective Effects of M2 Microglia on Neurons: A Review Focused on Exosomes and Secretory Proteins.

Miao Chai, Gang Su, Juan Gao, Wei Chen, Qionghui Wu, Ying Dong, He Wang, Deyi Chen, Yonghong Li, Xin Gao and 3 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Foods (Basel, Switzerland) · 2024
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Miao ChaiDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China.
Gang SuInstitute of Genetics, School of Basic Medical Sciences, Lanzhou University, 730030, Lanzhou, Gansu, China.
Juan GaoDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China.
Wei ChenDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China.
Qionghui WuDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China.
Ying DongDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China.
He WangDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China.
Deyi ChenDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China.
Yonghong LiNHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, 730000, Lanzhou, China.
Xin GaoDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China.
Ruixin LiDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China.
Tianfei MaDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China.
Zhenchang ZhangDepartment of Neurology, Lanzhou University Second Hospital, 730030, Lanzhou, Gansu, China. 13893647595@163.com.
Lanzhou University · CNLanzhou University Second Hospital · CNGansu Provincial Hospital · CN

Funding

Cuiying Graduate Supervisor Applicant Training Program of Lanzhou University Second Hospital 201802Science and Technology Planing Project of Chengguan District of Lanzhou City 2021-9-3the "Cuiying Technology Innovation" Planning Project of Lanzhou University Second Hospital CY2021-MS-B01the Health Industry Planning Project of Gansu Provincial GSWSKY2021-017the Lanzhou Science and Technology Development Guiding Plan Project 2019-ZD-51the National Natural Science Foundation of China 31870335the Natural Science Foundation of Gansu Provincial Department of Science and Technology 20JR5RA344
6 · The paper itself

Abstract

Microglia, as innate immune cells in the brain, closely monitor changes in the internal environment and participate in the maintenance of homeostasis in the central nervous system (CNS). Microglia can be polarized to the M1 or M2 phenotype in response to various stimuli in vivo or in vitro, affecting the functions of peripheral neurons. M2 microglia have attracted increasing attention in recent years owing to their beneficial effects on various diseases and injuries of the CNS, such as traumatic brain injury, stroke, Alzheimer's disease and multiple sclerosis. They exert neuroprotective effects by various mechanisms, e.g., suppressing inflammation, promoting the degradation of misfolded and aggregated proteins, promoting neurite growth, enhancing neurogenesis, inhibiting autophagy and apoptosis, promoting myelination, maintaining blood-brain barrier integrity, and enhancing phagocytic activity.This review summarizes the molecular mechanisms by which M2 microglia exert protective effects on neurons and provides a reference for the selection of therapeutic targets for CNS diseases.

Indexed as

ExosomesNeuroprotective AgentsStrokeHumansMicrogliaNeuronsNeuroprotective AgentsCNS diseasesmicroglia polarizationneuroinflammationneuroprotection

Identifiers

PMID36222957
OpenAlexW4304689824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.